Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapyMaxwell Chappell, Stefano Rivella, Tyler E. Papp et al.|Blood|2024Cited by 11
PB0776 Characterization of the Effects of Hydroxyurea and Crizanlizumab on Plasma Immunothrombosis Biomarkers in Patients with Sickle Cell DiseaseVeronica Bochenek, Kandace Gollomp, Jie Wu et al.|Research and Practice in Thrombosis and Haemostasis|2023Cited by 0
A Novel Direct Hemoglobin S Polymerization Inhibitor for the Treatment of Sickle Cell Disease - <i>In Vivo</i> Efficacy of Ilx-002 in Humanized MiceOsheiza Abdulmalik, Andrew N. Fleischman, Kandace Gollomp et al.|Blood|2024Cited by 0